By favoring GIP receptor potency, tirzepatide can fully engage the GIP pathway while keeping side effects more manageable
Personalized GLP-1 leverages the latest advancements in metabolic science to regulate appetite and boost metabolic rates, helping you naturally reduce calorie intake while feeling energized
Yes, all PlexusDx compounded GLP-1 medications and the Precision Peptide Genetic Test qualify as eligible expenses for HSA and FSA accounts
That level of precision is difficult to achieve consistently, especially for researchers still developing their technique
A popular dual agonist, tirzepatide (Mounjaro), activates both GLP-1R and GIPR, producing synergistic effects on insulin secretion, appetite suppression, and weight reduction (Table 1)
Important note: Although oral therapy is very effective, the treatment of a severe deficiency with pronounced neurological symptoms should always be carried out in close consultation with a doctor